BD SurePath™ Pap test combined with the scrutiny of the BD FocalPoint™ Slide Profiler helps improve the accuracy of the Pap result.
|
| The BD SurePath™ 13mm cell deposition area is the smallest viewing area of any Pap test on the market today. A reduced screening area enables your lab to be more efficient in reading slides and increasing turn-around times. |
 |
The BD SurePath™ proprietary Cell Enrichment process improves the ratio of diagnostic cells to non-diagnostic debris1, enabling a clear view for slide classification.
 |
| The BD FocalPoint™ Slide Profiler high throughput scanning improves lab processing capacity up to 33%.2 |
BD FocalPoint™ Slide Profiler Demonstrated 2:
|
- Numerically more HSIL+ slides for both BD SurePath™ liquid-based Pap test and conventional slides as compared to the current practice in clinical trials.
|
- 16% reduction in false-positives and a reduction in false-negatives on conventional slides.
|
- Statistically improved LSIL+ disease detection on conventional slides.
|
- Click here to see a figure of BD FocalPoint™ screening versus manual review.
|
|
| The BD FocalPoint™ Slide Profiler improves lab throughput by archiving for No Further Review (NFR) up to 25% of the qualified slides not requiring manual Cytologist review. |
| The BD SurePath™ Pap test is the only Pap test available today that with a 64.4% increase in HSIL+ detection3. |
| The BD FocalPoint™ Slide Profiler directs cytotechnologists attention to slides most likely to contain abnormality, improving disease detection over manual review.2 |
BD SurePath™ liquid-based Pap test
|
